機械的血栓除去装置の市場規模、シェア、成長分析：製品タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

機械的血栓除去装置の世界市場規模は2023年に16億5,000万米ドルと評価され、2024年の17億7,000万米ドルから2032年には30億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.1％で成長する見通しです。

機械的血栓除去装置の世界市場は、脳卒中や血管疾患の罹患率の上昇に牽引され、力強い成長を遂げています。この動向は、低侵襲手技に対するヘルスケア業界の嗜好の高まりと一致しており、血栓による虚血性脳卒中の治療において、機械的血栓除去術は従来の外科的アプローチに代わる好ましい選択肢として位置づけられています。患者や医療提供者は、治療結果を向上させながら外傷や回復時間を最小限に抑える治療オプションを優先しており、こうした機器の採用を後押ししています。技術の進歩、人口の高齢化、ヘルスケアインフラの改善といった要因が、市場の拡大をさらに後押ししています。主要企業は足場固めのために製品革新や提携を積極的に進めているが、コストの制約や地域的な認知度の低さといった課題は依然として残っています。効果的な血栓除去ソリューションに対する需要は、市場の継続的な成長を示唆しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢
• 特許分析

機械的血栓除去装置市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 吸引カテーテル
• コイルレトリーバー
• ステント回収装置
• その他の装置

機械的血栓除去装置市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 虚血性脳卒中
• 肺塞栓症（PE）
• 深部静脈血栓症（DVT）

機械的血栓除去装置市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• 専門クリニック

機械的血栓除去装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic plc（Ireland）
• Stryker Corporation（USA）
• Penumbra, Inc.（USA）
• Boston Scientific Corporation（USA）
• Terumo Corporation（Japan）
• Johnson & Johnson（USA）
• Abbott Laboratories（USA）
• Becton, Dickinson and Company（USA）
• Teleflex Incorporated（USA）
• AngioDynamics, Inc.（USA）
• Merit Medical Systems, Inc.（USA）
• Edwards Lifesciences Corporation（USA）
• Cook Medical（USA）
• Acandis GmbH（Germany）
• Phenox GmbH（Germany）
• MicroVention, Inc.（USA）
• Rapid Medical（Israel）
• Vesalio（USA）
• Inari Medical, Inc.（USA）
• Balt USA LLC（USA）

結論と提言

Global Mechanical Thrombectomy Devices Market size was valued at USD 1.65 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 3.06 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global market for mechanical thrombectomy devices is experiencing robust growth, driven by the rising incidence of strokes and vascular diseases. This trend aligns with the healthcare industry's increasing preference for minimally invasive procedures, positioning mechanical thrombectomy as a favorable alternative to traditional surgical approaches for treating ischemic strokes caused by blood clots. Patients and providers prioritize treatment options that minimize trauma and recovery time while enhancing outcomes, bolstering the adoption of these devices. Factors such as technological advancements, an aging population, and improved healthcare infrastructure further fuel market expansion. Key players are actively pursuing product innovation and collaborations to strengthen their foothold, though challenges such as cost constraints and limited regional awareness persist. The demand for effective clot removal solutions suggests continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mechanical Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mechanical Thrombectomy Devices Market Segments Analysis

Global Mechanical Thrombectomy Devices Market is segmented by Product Type, Application, End-user and region. Based on Product Type, the market is segmented into Aspiration Catheters, Coil Retrievers, Stent Retrievers, and Other Devices. Based on Application, the market is segmented into Ischemic Stroke, Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT). Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mechanical Thrombectomy Devices Market

The growth of the global mechanical thrombectomy devices market is primarily fueled by the increasing prevalence of strokes, especially ischemic strokes. These devices play a crucial role in efficiently extracting blood clots from obstructed arteries, subsequently lowering the chances of disability and mortality linked to strokes. With an aging global population and a rise in risk factors like hypertension, diabetes, and obesity, there is an anticipated surge in the demand for mechanical thrombectomy procedures. This trend underscores the urgent need for advanced medical technologies to address the escalating challenges posed by stroke-related health issues.

Restraints in the Global Mechanical Thrombectomy Devices Market

The Global Mechanical Thrombectomy Devices market faces notable restraints primarily due to the high costs associated with both the devices and the procedures themselves. The financial burden, which includes expenses for hospitalization and post-operative care, can deter health systems, insurance providers, and patients from embracing these technologies. This economic challenge may hinder broader acceptance and utilization of mechanical thrombectomy devices, as the potential for significant out-of-pocket expenses poses a substantial barrier to access. Consequently, the overall growth and adoption of mechanical thrombectomy solutions may be restricted as stakeholders navigate these financial concerns.

Market Trends of the Global Mechanical Thrombectomy Devices Market

The Global Mechanical Thrombectomy Devices market is witnessing a dynamic trend characterized by rapid technological advancements and innovative product development. Manufacturers are increasingly focusing on creating highly efficient and precise devices that prioritize minimally invasive procedures for clot removal. This trend involves significant improvements in device design and imaging technologies, along with the integration of robotic systems and navigation technologies, aimed at enhancing procedural effectiveness and patient safety. These innovations not only improve clinical outcomes but also drive market growth as healthcare providers seek more sophisticated solutions to address the challenges of thromboembolic events, thus shaping the future landscape of the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Mechanical Thrombectomy Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Aspiration Catheters
• Coil Retrievers
• Stent Retrievers
• Other Devices

Global Mechanical Thrombectomy Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Ischemic Stroke
• Pulmonary Embolism (PE)
• Deep Vein Thrombosis (DVT)

Global Mechanical Thrombectomy Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Mechanical Thrombectomy Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-user)
  • US
  • Canada
• Europe (Product Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phenox GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vesalio (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt USA LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations